Human Papillomavirus Infections Recruiting Phase 2 Trials for Durvalumab (DB11714)

Also known as: Human Papillomavirus Infection / Human Papilloma Virus Infection / Papillomavirus Infections / Human papillomavirus infection (disorder) / Papovavirus infection subgroup A (disorder) [Ambiguous] / Papovavirus infection subgroup A (disorder) / Human papilloma virus infection of skin / Disease caused by Papillomavirus (disorder) / Papilloma viral infection / Papilloma viral infection NOS / Papilloma viral infections

IndicationStatusPhase
DBCOND0046485 (Human Papillomavirus Infections)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02827838Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx CancerTreatment